Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1111/bjh.16770

Type

Journal article

Publication Date

2020-08-01T00:00:00+00:00

Volume

190

Pages

e160 - e162

Keywords

EMD, IMRT, combination therapy, plasmacytoma, pleura, Aged, Antineoplastic Combined Chemotherapy Protocols, Bortezomib, Combined Modality Therapy, Cyclophosphamide, Dexamethasone, Fatal Outcome, Female, Humans, Lenalidomide, Melphalan, Multiple Myeloma, Pleural Neoplasms, Prednisolone, Thalidomide